IPO registrations (S-1, F-1) · Registrants

ATHERSYS, INC / NEW

SEC CIK
1368148 · filings on EDGAR ↗
Former names
BTHC VI Inc (2006–2007)
Registration
Form S-1, first filed 2007-07-10, last 2023-11-22; 5 initial registrations, 8 amendments
Outcome
Final prospectus filed 2012-10-26; declared effective 2007-10-18
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
3201 CARNEGIE AVENUE, Cleveland, OH 44115-2634
EIN
20-4864095
EDGAR entity type
operating
Insiders and CEO pay
ATHERSYS, INC / NEW on the corporate pages

Filings 41

FiledFormWhat it isName as filedEDGAR
2007-07-10S-1S-1 (registration)BTHC VI Inc0000950152-07-005716 ↗
2007-09-12S-1/AS-1/A (amendment)ATHERSYS, INC / NEW0000950152-07-007492 ↗
2007-10-18EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-07-004107 ↗
2010-01-28EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-10-000367 ↗
2011-12-09S-1S-1 (registration)ATHERSYS, INC / NEW0001193125-11-336755 ↗
2012-01-10S-1/AS-1/A (amendment)ATHERSYS, INC / NEW0001193125-12-007824 ↗
2012-01-17EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-12-000203 ↗
2012-04-09EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-12-000982 ↗
2012-04-16EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-12-001061 ↗
2012-10-09S-1S-1 (registration)ATHERSYS, INC / NEW0001193125-12-417686 ↗
2012-10-17S-1/AS-1/A (amendment)ATHERSYS, INC / NEW0001193125-12-426155 ↗
2012-10-23S-1/AS-1/A (amendment)ATHERSYS, INC / NEW0001193125-12-431688 ↗
2012-10-25S-1MEFS-1MEF (added securities)ATHERSYS, INC / NEW0001193125-12-435939 ↗
2012-10-25EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-12-003087 ↗
2012-10-26424B4424B4 (final prospectus)ATHERSYS, INC / NEW0001193125-12-436494 ↗
2013-01-22EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-13-000250 ↗
2013-04-05EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-13-000894 ↗
2013-11-07EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-13-003220 ↗
2014-03-27EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-14-000795 ↗
2015-02-09EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-15-000336 ↗
2016-01-13EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-16-003518 ↗
2017-03-21EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-17-000614 ↗
2018-02-13EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-18-000435 ↗
2019-11-25EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-19-002658 ↗
2020-01-29EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-20-000184 ↗
2020-06-09EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-20-001381 ↗
2020-08-21EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-20-002223 ↗
2021-07-07EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-21-002669 ↗
2023-04-13EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-23-000919 ↗
2023-05-10EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-23-001367 ↗
2023-06-07EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-23-001660 ↗
2023-07-14S-1S-1 (registration)ATHERSYS, INC / NEW0001437749-23-019967 ↗
2023-07-26S-1/AS-1/A (amendment)ATHERSYS, INC / NEW0001437749-23-020653 ↗
2023-07-28S-1/AS-1/A (amendment)ATHERSYS, INC / NEW0001437749-23-020944 ↗
2023-08-07S-1/AS-1/A (amendment)ATHERSYS, INC / NEW0001437749-23-022348 ↗
2023-08-11EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-23-002358 ↗
2023-08-21424B4424B4 (final prospectus)ATHERSYS, INC / NEW0001437749-23-024254 ↗
2023-09-21EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-23-002718 ↗
2023-11-09S-1S-1 (registration)ATHERSYS, INC / NEW0001437749-23-031313 ↗
2023-11-22S-1/AS-1/A (amendment)ATHERSYS, INC / NEW0001437749-23-032817 ↗
2023-11-29EFFECTEFFECT (declared effective)ATHERSYS, INC / NEW9999999995-23-003488 ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Brigante David FTenPercentOwner12006
Diamond George LTenPercentOwner12006
Halter Financial Investments GP LLCTenPercentOwner12006
Halter Financial Investments LPTenPercentOwner12006
HALTER TIMOTHY PDirector,Officer,TenPercentOwnerCEO, Pres, CFO, Chairman & Sec12006
Rosenberg MaratTenPercentOwner12006
Brunden Kurt LOfficerVice President22007
Campbell Laura KOfficerSenior Vice Pres Finance; Vice Pres Finance; Vice President; Vice President of Finance432007–2021
Davis JordanDirector82007–2017
Deans Robert JOfficerExecutive Vice President; Sr. Vice President; Vice President162007–2015
Harrington John JDirector,Officer; OfficerChief Scientific Officer; Dir. & Chief Scientific Off.; EVP & Chief Scientific Officer; Exec Vice Pres and CSO492007–2022
Lehmann William JROfficerInterim CEO; Interim CEO, President, COO; President; President and COO; President & COO; President, COO492007–2022
LOOP FLOYD D MDDirector52007–2010
LUBIN DANIEL CTenPercentOwner12007
MILNE GEORGE M JRDirector62007–2011
MULLIGAN WILLIAM CDirector42007–2009person page Fuzzy
ORBIMED ADVISORS LLCDirectorOther; Director,TenPercentOwner; TenPercentOwner82007–2011
Radius Venture Partners III, LLCTenPercentOwner12007
RADIUS VENTURE PARTNERS III L PTenPercentOwner12007
Radius Venture Partners III QP, L.P.TenPercentOwner12007
Radius Venture Partners II, LLCTenPercentOwner12007
RADIUS VENTURE PARTNERS II LPTenPercentOwner12007
SHEFFERY MICHAEL BDirector; Director,TenPercentOwner102007–2010
Van Bokkelen GilDirector,OfficerChairman and CEO; Chief Executive Officer; Chmn & Chief Executive Officer502007–2020
Caduceus Private Investment III LPTenPercentOwner12007
Randall LorinDirector192007–2021
ISALY SAMUEL DDirector,TenPercentOwner; TenPercentOwner62008–2011
WYSZOMIERSKI JACK LDirector182010–2023
Babiss LeeDirector142010–2020
Kola IsmailDirector212010–2023
OrbiMed Capital GP III LLCTenPercentOwner12011
TRAUB KENNETH HDirector152012–2022
HEALIOS K.K.Other; TenPercentOwner22018–2020
Kagimoto TadahisaDirector; Director,TenPercentOwner32018–2020
Macleod ivorOfficerChief Financial Officer92020–2022
Shah Baiju R.Director32020–2021person page Fuzzy
Wasman JaneDirector52020–2023
Kalin Katherine BachDirector32020–2021
Camardo Daniel A.Director,OfficerCEO; Chief Executive Officer92022–2023
Hansen MaiaOfficerChief Operating Officer; COO122022–2023
Rosado KaseyOfficerInterim, CFO12022
Nolan Joseph PatrickDirector22023
MAYHUGH NEEMADirector22023

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2023-05-01ATHERSYS, INC / NEWBiotechnology$3,537,600$3,537,60041
2012-03-22ATHERSYS, INC / NEWBiotechnology$18,000,004$9,000,002201

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.